Elinafide

CAS No. 162706-37-8

Elinafide( —— )

Catalog No. M36163 CAS No. 162706-37-8

Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 67 Get Quote
5MG 93 Get Quote
10MG 144 Get Quote
25MG 266 Get Quote
50MG 364 Get Quote
100MG 512 Get Quote
500MG 1071 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Elinafide
  • Note
    Research use only, not for human use.
  • Brief Description
    Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.
  • Description
    Elinafide, a dinaphthylimide cytotoxic agent, is a DNA-targeted anticancer agent that has shown antitumor activity in in vitro and in vivo assays.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    162706-37-8
  • Formula Weight
    520.58
  • Molecular Formula
    C31H28N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1C=2C=3C(C(=O)N1CCNCCCNCCN4C(=O)C=5C=6C(C4=O)=CC=CC6C=CC5)=CC=CC3C=CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CBFβ Inhibitor

    CBFβ Inhibitor is a cell-permeable CBFβ inhibitor and inhibits its association with Runx1.

  • Doxifluridine

    Doxifluridine is a Thymidylate synthase inhibitor.

  • GS-9191

    GS-9191 is a potent inhibitor of DNA polymerase alpha and ? , a prodrug of the novel nucleoside analogue 9-(2-phosphonomethoxyethyl)guanine (PMEG) , which penetrates the skin and is metabolized in the epithelium to an active nucleoside triphosphate analogue.